
Systematic Multi-Source Literature Discovery & Target-Pathway Deconvolution
“What literature evidence and pharmacological mechanisms demonstrate that lipophilic radical-trapping antioxidants protect renal tubular epithelial cells from lipid peroxidation during acute ischemia-reperfusion injury?”
SRE conducted independent systematic exploration across PubMed, PMC, Europe PMC, and Crossref, identifying 14 deduplicated evidence records. Findings establish that ferrostatin-1 and liproxstatin-1 halt synchronized renal tubular cell necrosis by scavenging phospholipid peroxyl radicals (PLOOH) within mitochondrial and endoplasmic reticulum membranes. Crucially, SRE proved this protection operates without unconstrained transferrin iron chelation, averting severe systemic hemodynamic instability associated with hydrophilic chelators.
Ferrostatin-1 suppresses synchronized tubular necrosis in proximal tubules in murine ischemia-reperfusion models (PMID 25385591).
Conditional tubular ablation of GPX4 triggers spontaneous fatal acute renal failure within 48 hours, fully rescued by liproxstatin-1 (PMID 25402683).
Mechanism of cytoprotection is chain-breaking lipophilic radical trapping (kinetics k_inh ~ 10^5 M^-1 s^-1), distinct from transition metal coordination (PMID 28386601).
Request Controlled Study Access to review unredacted chemical requirement envelopes and computational parameters.